Gland Pharma (NSE:GLAND) Total Assets : ₹108,669 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Gland Pharma Total Assets?

Gland Pharma's Total Assets for the quarter that ended in Sep. 2024 was ₹108,669 Mil.

Warning Sign:

If a company builds assets at 24.2% a year, faster than its revenue growth rate of 19.9% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Gland Pharma's average Total Assets Growth Rate was -1.80% per year. During the past 3 years, the average Total Assets Growth Rate was 29.10% per year. During the past 5 years, the average Total Assets Growth Rate was 24.20% per year.

During the past 7 years, Gland Pharma's highest 3-Year average Total Assets Growth Rate was 29.10%. The lowest was 18.10%. And the median was 21.45%.

Total Assets is connected with ROA %. Gland Pharma's annualized ROA % for the quarter that ended in Sep. 2024 was 6.02%. Total Assets is also linked to Revenue through Asset Turnover. Gland Pharma's Asset Turnover for the quarter that ended in Sep. 2024 was 0.13.

Gland Pharma Total Assets Historical Data

The historical data trend for Gland Pharma's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gland Pharma Total Assets Chart

Gland Pharma Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Assets

Get a 7-Day Free Trial

40,860.39

64,960.82

78,336.21

87,775.35

106,612.46

Gland Pharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Assets	Get a 7-Day Free Trial															102,928.38	-	106,612.46	-	108,668.94

Gland Pharma Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Gland Pharma's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (A: Mar. 2024 )	+	Total Liabilities (A: Mar. 2024 )
	=	87238.43	+	19374.03
	=	106,612

Gland Pharma's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2024 )	+	Total Liabilities (Q: Sep. 2024 )
	=	87880	+	20788.94
	=	108,669

Gland Pharma (NSE:GLAND) Total Assets Explanation

Total Assets is connected with ROA %.

Gland Pharma's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %	=	Net Income (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	6541.28	/	( (0	+	108668.94)	/ 1 )
	=	6541.28	/	108668.94
	=	6.02 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Gland Pharma's Asset Turnover for the quarter that ended in Sep. 2024 is

	Asset Turnover
=	Revenue (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
=	14058.33	/	( (0	+	108668.94)	/ 1 )
=	14058.33	/	108668.94
=	0.13

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Gland Pharma Total Assets Related Terms

Thank you for viewing the detailed overview of Gland Pharma's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Gland Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gland Pharma Ltd (NSE:GLAND) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

543245:India

Address

Plot No. 11 and 84, TSIIC Phase: IV, Pashamylaram (V), Patancheru (M), Sangareddy District, Hyderabad, TG, IND, 502307

Website

https://www.glandpharma.com

Gland Pharma Ltd is engaged in the development, manufacturing, and marketing of complex injectables. The company's key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. The group is also involved in vast range of therapeutic categories that include Anti-Infectives, Anesthetics, Anti-Coagulants and their Antidotes, Anti-Malarial, Cardiology and more - to Hormones and related Drugs, Fertility Supplements and Gnrh Agonists and Antagonists. Geographically, it derives a majority of revenue from the USA.

Gland Pharma Headlines

No Headlines